Cellectis Sa Stock Price Prediction

CLLS Stock  USD 2.13  0.01  0.47%   
At this time, The RSI of Cellectis' share price is at 50 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Cellectis, making its price go up or down.

Oversold Vs Overbought

50

 
Oversold
 
Overbought
The successful prediction of Cellectis' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Cellectis and does not consider all of the tangible or intangible factors available from Cellectis' fundamental data. We analyze noise-free headlines and recent hype associated with Cellectis SA, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting Cellectis' stock price prediction:
EPS Estimate Next Quarter
(0.25)
EPS Estimate Current Year
(0.70)
EPS Estimate Next Year
(0.76)
Wall Street Target Price
6.5
EPS Estimate Current Quarter
(0.21)
Using Cellectis hype-based prediction, you can estimate the value of Cellectis SA from the perspective of Cellectis response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Cellectis to buy its stock at a price that has no basis in reality. In that case, they are not buying Cellectis because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Cellectis after-hype prediction price

    
  USD 2.13  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Cellectis Basic Forecasting Models to cross-verify your projections.
Intrinsic
Valuation
LowRealHigh
0.193.386.57
Details
Naive
Forecast
LowNextHigh
0.042.215.40
Details
6 Analysts
Consensus
LowTargetHigh
6.837.508.33
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.17-0.17-0.17
Details

Cellectis After-Hype Price Prediction Density Analysis

As far as predicting the price of Cellectis at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cellectis or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Cellectis, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Cellectis Estimiated After-Hype Price Volatility

In the context of predicting Cellectis' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Cellectis' historical news coverage. Cellectis' after-hype downside and upside margins for the prediction period are 0.11 and 5.32, respectively. We have considered Cellectis' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
2.13
2.13
After-hype Price
5.32
Upside
Cellectis is relatively risky at this time. Analysis and calculation of next after-hype price of Cellectis SA is based on 3 months time horizon.

Cellectis Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Cellectis is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cellectis backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cellectis, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.04 
3.19
 0.00  
  0.01 
5 Events / Month
14 Events / Month
In about 5 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
2.13
2.13
0.00 
2,658  
Notes

Cellectis Hype Timeline

Cellectis SA is currently traded for 2.13. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.01. Cellectis is expected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is expected to be very small, whereas the daily expected return is currently at -0.04%. %. The volatility of related hype on Cellectis is about 1205.84%, with the expected price after the next announcement by competition of 2.12. About 15.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.65. Some equities with similar Price to Book (P/B) outperform the market in the long run. Cellectis SA recorded a loss per share of 1.16. The entity had not issued any dividends in recent years. Given the investment horizon of 90 days the next expected press release will be in about 5 days.
Check out Cellectis Basic Forecasting Models to cross-verify your projections.

Cellectis Related Hype Analysis

Having access to credible news sources related to Cellectis' direct competition is more important than ever and may enhance your ability to predict Cellectis' future price movements. Getting to know how Cellectis' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cellectis may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
SGTXSigilon Therapeutics(5.67)8 per month 6.43  0.11  12.46 (14.07) 442.39 
DMACDiaMedica Therapeutics(0.04)5 per month 1.94  0.13  6.41 (3.29) 14.14 
NBSENeuBase Therapeutics(0.18)1 per month 0.00 (0.19) 8.42 (11.84) 39.09 
SLNOSoleno Therapeutics 1.49 10 per month 2.50  0.03  5.87 (4.22) 13.40 
GNFTGenfit(0.01)4 per month 4.52 (0.01) 6.17 (6.16) 30.76 
CYTCyteir Therapeutics 0.09 2 per month 2.57  0.08  10.00 (5.26) 36.14 
ERYPErytech Pharma SA 0.02 3 per month 0.00 (0.03) 12.68 (8.25) 46.27 
ELYMEliem Therapeutics 0.25 4 per month 0.00 (0.19) 6.21 (9.35) 34.87 
HCWBHCW Biologics 0.33 4 per month 8.22  0.07  22.00 (16.67) 352.85 
IPHAInnate Pharma(0.03)9 per month 0.00 (0.12) 7.96 (10.68) 29.50 
INBXInhibrx 1.00 6 per month 2.72  0.01  5.54 (6.11) 16.80 
ANEBAnebulo Pharmaceuticals(0.02)5 per month 0.00 (0.02) 8.61 (11.48) 76.00 
CRNXCrinetics Pharmaceuticals(1.21)11 per month 2.47 (0.01) 3.67 (3.45) 16.75 
PASGPassage Bio 0.03 8 per month 5.91  0.1  12.07 (10.45) 32.24 
RGNXRegenxbio 0.16 10 per month 0.00 (0.06) 5.72 (7.20) 32.22 
LIANLianBio ADR 0.00 0 per month 3.34  0.01  6.76 (5.00) 20.98 
KZRKezar Life Sciences(0.20)7 per month 2.74  0.05  4.93 (3.88) 51.13 
FHTXFoghorn Therapeutics(0.47)10 per month 4.41  0.01  8.50 (6.81) 34.64 
STTKShattuck Labs(0.01)10 per month 0.00 (0.17) 6.93 (9.82) 51.03 
GLUEMonte Rosa Therapeutics(0.74)8 per month 3.74  0.09  8.10 (8.18) 102.66 
KYMRKymera Therapeutics(0.63)11 per month 0.00 (0.05) 4.84 (4.74) 18.10 
NRIXNurix Therapeutics 0.02 8 per month 0.00 (0.08) 5.22 (4.73) 22.77 

Cellectis Additional Predictive Modules

Most predictive techniques to examine Cellectis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cellectis using various technical indicators. When you analyze Cellectis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Cellectis Predictive Indicators

The successful prediction of Cellectis stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Cellectis SA, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Cellectis based on analysis of Cellectis hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Cellectis's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Cellectis's related companies.
 2021 2022 2023 2024 (projected)
Days Sales Outstanding100.514.711.2K11.7K
PTB Ratio1.710.821.893.61

Story Coverage note for Cellectis

The number of cover stories for Cellectis depends on current market conditions and Cellectis' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cellectis is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cellectis' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Other Macroaxis Stories

Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios

Cellectis Short Properties

Cellectis' future price predictability will typically decrease when Cellectis' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Cellectis SA often depends not only on the future outlook of the potential Cellectis' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cellectis' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding57 M
Cash And Short Term Investments203.8 M

Additional Tools for Cellectis Stock Analysis

When running Cellectis' price analysis, check to measure Cellectis' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cellectis is operating at the current time. Most of Cellectis' value examination focuses on studying past and present price action to predict the probability of Cellectis' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cellectis' price. Additionally, you may evaluate how the addition of Cellectis to your portfolios can decrease your overall portfolio volatility.